Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Envair Technology is a specialist provider of containment and clean air solutions for the pharmaceutical, healthcare, and biotechnology sectors. The company was established through the integration of industry-leading brands Envair and ONFAB, combining expertise in rigid and flexible containment technologies. Their product suite includes isolators, laminar flow cabinets, and modular cleanrooms, which are critical for protecting operators from hazardous materials and ensuring product sterility during drug compounding and manufacturing. Serving a global market, the company provides essential infrastructure for hospital pharmacies and pharmaceutical production facilities. In November 2022, Envair Technology was acquired by Esco Lifesciences, a global leader in life sciences tools, to enhance its portfolio of containment and pharmacy automation solutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Envair Technology.